Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank.

International journal of chronic obstructive pulmonary disease

Volumn 4, Issue , 2009, Pages 443-452

  Tonelli, Adriano R ^a   Rouhani, Farshid ^a   Li, Ning ^a   Schreck, Pam ^a   Brantly, Mark L ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CONVALESCENCE; ENZYME REPLACEMENT; ENZYMOLOGY; FEMALE; FORCED EXPIRATORY VOLUME; GENETICS; GENOTYPE; HEALTH CARE FACILITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; SMOKING CESSATION; SPIROMETRY; TIME; TREATMENT OUTCOME;

ALPHA 1-ANTITRYPSIN; ALPHA 1-ANTITRYPSIN DEFICIENCY; ENZYME REPLACEMENT THERAPY; FEMALE; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; INJECTIONS, INTRAVENOUS; LUNG; MALE; MIDDLE AGED; PHENOTYPE; RECOVERY OF FUNCTION; SMOKING CESSATION; SPIROMETRY; TIME FACTORS; TISSUE BANKS; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 77949329900     PISSN: None     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/copd.s8577     Document Type: Article

References (0)